Valkyrie Pharma Deca selected by AnabolicLab two years following the first analysis.
January 30, 2019 – AnabolicLab has tested Valkrie Pharma products on several occasions. And now AnabolicLab is getting around to testing some of the products for the second time.
Valkyrie Pharma Deca 300 performed well when AnabolicLab first tested the nandrolone decanoate product back in April 2016. AnabolicLab decided to analyze the product again in March 2018.
— Anabolic Lab (@AnabolicLab) February 2, 2019
The AnabolicLab program reveals that you can not judge a product by a single test.
Valkyrie Pharma Deca 300 is listed as containing 300 milligrams of nandrolone decanoate per milliliter of injectable solution.
When it was tested in April 2016, Deca 300 was found to contain 271.9 mg/ml nandrolone decanoate. This was good since it fell within 10% of the label claim.
However, Valkrie Pharma Deca 300 did not do quite so well in March 2018. The SIMEC HPLC-UV analysis revealed that this batch of Deca 300 contained 216.2 mg/ml. This made it 28% underdosed.
The 2018 lab test results may not be the worst results but they are not as good as the 2016 lab test results.
This is why we should exercise caution when attempting to determine the overall quality of a product or a brand from a single lab test. After all, results could differ from batch to batch or product to product.